Atlas Trials

Immunotherapy for Hepatocellular Carcinoma

Clinical trial NCT06241326 · RECRUITING

Trial details

NCT number
NCT06241326
Sponsor
The First Affiliated Hospital with Nanjing Medical University
Status
RECRUITING
Study type
OBSERVATIONAL
Hepatocellular CarcinomaImmunotherapy
Start date
2024-03-01
Primary completion
2026-12-31
Enrollment
11000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.